Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase 3 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Prostatic Hyperplasia 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Dutasteride × Clear all
NCT00470834 2017-02-27

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

GlaxoSmithKline

Phase 4 Completed
127 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00375765 2017-01-19

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

GlaxoSmithKline

Phase 4 Completed
40 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT00363311 2017-01-18

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

GlaxoSmithKline

Phase 4 Completed
302 enrolled 37 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡